AMAG Pharmaceuticals Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
9,602.00
135,817.00
32,779.00
2,483.00
199,228.00
65,761
Depreciation, Depletion & Amortization
1,185.00
6,984.00
69,103.00
99,886.00
155,538.00
172,223
Other Funds
51.00
40,030.00
7,651.00
94,301.00
42,489.00
78,633
Funds from Operations
6,530.00
7,628.00
149,575.00
188,547.00
103,243.00
68,995
Changes in Working Capital
13,304.00
3,786.00
41,103.00
57,675.00
4,665.00
8,195
Net Operating Cash Flow
6,774.00
11,414.00
108,472.00
246,222.00
107,908.00
60,800
Capital Expenditures
5,066.00
147.00
1,259.00
5,460.00
64,788.00
Sale of Fixed Assets & Businesses
2,970.00
103.00
562.00
-
-
Purchase/Sale of Investments
9,016.00
159,821.00
215,988.00
67,244.00
167,708.00
Net Investing Cash Flow
13,935.00
432,942.00
899,041.00
72,704.00
102,920.00
Issuance/Reduction of Debt, Net
-
519,749.00
484,746.00
17,502.00
234,408.00
Net Financing Cash Flow
1,402.00
513,838.00
899,978.00
127,918.00
293,019.00
Net Change in Cash
19,307.00
92,310.00
109,409.00
45,600.00
82,191.00
Free Cash Flow
8,406.00
11,267.00
107,213.00
240,762.00
98,920.00
Deferred Taxes & Investment Tax Credit
-
153,159.00
5,007.00
7,279.00
178,421.00
41,166
Net Assets from Acquisitions
-
595,602.00
682,356.00
-
-
Other Sources
-
2,883.00
-
-
-
Change in Capital Stock
1,453.00
34,119.00
422,883.00
16,115.00
16,122.00
Other Uses
2,823.00
-
-
-
-
About AMAG Pharmaceuticals
View Profile
